GMP Final Rule Takes Effect

News
Article

FDA's Final Rule titled "Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals" takes effect Monday, Dec. 8, 2008.

Rockville, MD (Dec. 4)-FDA's Final Rule titled “Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals” will take effect on Monday, Dec. 8, 2008. As the “culmination of the first increment of modifications to [CFR] parts 210 and 211,” the rule revises CGMP requirements primarily for aseptic processing, the use of asbestos filters, and the verification of performance operations by a second individual.

Regarding aseptic processing, the rule revises CFR section 211.113(b), which now clarifies that the required written procedures to prevent microbial contamination of sterile drug products must include procedures for the validation of all aseptic processes in addition to sterilization processes. The rule also revises CFR section 211.84(d)(6), requiring that microbiological testing be conducted before the use of each lot of component, drug product, or closure “with potential for microbiological contamination.” CFR section 211.94(c), regarding the depyrogenation process for drug-product containers, and CFR section 211.110(a), regarding bioburden testing of in-process control procedures and materials, are also revised.

The final rule revises CFR section 210.3(b)(6) and 211.72 to eliminate provisions that permitted limited use of asbestos-containing filters during the processing of injectable drug products. The regulations now include the statement, “The use of an asbestos-containing filter is prohibited.”

The final rule revises the CGMP regulations regarding “which operations may be performed by automated equipment and verified by a person, rather than one person performing an operation and another person verifying that the operation was correctly performed.” The purpose of the change was to eliminate any misinterpretation that a person was required to repeat by hand all calculations performed by automated equipment. The rule also revises CFR sections 211.101(c) and (d), charge-in of components and containers; 211.103, calculation of yields; 211.182, equipment cleaning and maintenance; and 211.188(b)(11), batch-production and control records.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes